ArticlePloS one2022

Disruptions in hepatic glucose metabolism are involved in the diminished efficacy after chronic treatment with glucokinase activator.

Yoshinori Tsumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.